Company intelligence / Profile preview

OMNIFARMA KIEV

Kyiv, Ukraine
Ownership
Private
Employees
~150
Development stage
Other
01

Overview

Omnifarma is a Ukrainian pharmaceutical company founded in 2008 that specializes in the development, production, and marketing of innovative healthcare products and dietary supplements. The company is most recognized for its flagship product, White Coal (Bilyi Vuhillya), a high-efficiency silicon-based adsorbent used for detoxification and gastrointestinal health. Beyond adsorbents, Omnifarma maintains a diverse portfolio of products targeting hepatology, rheumatology, and general wellness. The company focuses on evidence-based formulations and has established a strong commercial presence in Ukraine and several international markets. Omnifarma operates its own manufacturing and R&D initiatives to ensure high-quality standards for its over-the-counter and supplemental offerings.

Therapeutic areas
Infectious DiseasesRheumatologyOtherGastroenterology
Modalities
Small moleculeNutraceutical
Industry
Biotech
02

Drug pipeline

2 assets

colloidal silicon dioxide

3

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on OMNIFARMA KIEV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMNIFARMA KIEV.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call